Roivant Sciences Ltd.
ROIV
Rankning i aktier
#979
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
Aktiekurs
$33.73
Senast synkroniserad: 2026-07-31
Marknadsvärde
$24.37B
Förändring (1 dag)
-2.28%
Förändring (1 år)
88.77%
Land
GB
Handel Roivant Sciences Ltd. (ROIV)
Kategori
Healthcare
Historik för aktiesplit för Roivant Sciences Ltd. (ROIV)
Aktien Roivant Sciences Ltd. (symbol: ROIV) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En ROIV-aktie köpt före Oct 21, 2026 motsvarar nu 0 ROIV-aktier.
Den senaste spliten skedde den Oct 21, 2026.
En ROIV-aktie köpt före Oct 21, 2026 motsvarar nu 0 ROIV-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
